Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.

den Haan J, Morrema THJ, Rozemuller AJ, Bouwman FH, Hoozemans JJM.

Acta Neuropathol Commun. 2018 Aug 9;6(1):75. doi: 10.1186/s40478-018-0577-2.

2.

Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges.

Abu-Rumeileh S, Redaelli V, Baiardi S, Mackenzie G, Windl O, Ritchie DL, Didato G, Hernandez-Vara J, Rossi M, Capellari S, Imperiale D, Rizzone MG, Belotti A, Sorbi S, Rozemuller AJM, Cortelli P, Gelpi E, Will RG, Zerr I, Giaccone G, Parchi P.

Ann Neurol. 2018 Jul 26. doi: 10.1002/ana.25300. [Epub ahead of print]

PMID:
30048013
3.

Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.

Groot C, Tolboom N, Ikonomovic MD, Lammertsma AA, Boon BDC, Barkhof F, Scheltens P, Klunk WE, Rozemuller AJM, Ossenkoppele R, van Berckel BNM.

J Alzheimers Dis. 2018;65(1):71-77. doi: 10.3233/JAD-180316.

PMID:
30040724
4.

Neuropathology and cognitive performance in self-reported cognitively healthy centenarians.

Ganz AB, Beker N, Hulsman M, Sikkes S, Netherlands Brain Bank, Scheltens P, Smit AB, Rozemuller AJM, Hoozemans JJM, Holstege H.

Acta Neuropathol Commun. 2018 Jul 23;6(1):64. doi: 10.1186/s40478-018-0558-5.

5.

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.

Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, IJpma AS, van IJcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V; International Parkinsonism Genetics Network.

Lancet Neurol. 2018 Jul;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0. Epub 2018 Jun 7.

PMID:
29887161
6.

Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.

Hondius DC, Eigenhuis KN, Morrema THJ, van der Schors RC, van Nierop P, Bugiani M, Li KW, Hoozemans JJM, Smit AB, Rozemuller AJM.

Acta Neuropathol Commun. 2018 Jun 4;6(1):46. doi: 10.1186/s40478-018-0540-2.

7.

Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.

Boon BDC, Hoozemans JJM, Lopuhaä B, Eigenhuis KN, Scheltens P, Kamphorst W, Rozemuller AJM, Bouwman FH.

J Neuroinflammation. 2018 May 29;15(1):170. doi: 10.1186/s12974-018-1180-y.

8.

Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.

Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, van de Berg WDJ.

Neuropathol Appl Neurobiol. 2018 May 24. doi: 10.1111/nan.12501. [Epub ahead of print]

PMID:
29797340
9.

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.

Meeter LHH, Vijverberg EG, Del Campo M, Rozemuller AJM, Donker Kaat L, de Jong FJ, van der Flier WM, Teunissen CE, van Swieten JC, Pijnenburg YAL.

Neurology. 2018 Apr 3;90(14):e1231-e1239. doi: 10.1212/WNL.0000000000005261. Epub 2018 Mar 7.

10.

Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.

Race B, Williams K, Hughson AG, Jansen C, Parchi P, Rozemuller AJM, Chesebro B.

Acta Neuropathol Commun. 2018 Feb 20;6(1):13. doi: 10.1186/s40478-018-0516-2.

11.

A Laser Microdissection-Liquid Chromatography-Tandem Mass Spectrometry Workflow for Post-mortem Analysis of Brain Tissue.

Hondius DC, Hoozemans JJM, Rozemuller AJM, Li KW, Smit AB.

Methods Mol Biol. 2018;1723:371-383. doi: 10.1007/978-1-4939-7558-7_21.

PMID:
29344872
12.

Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.

Louwersheimer E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, Sistermans EA, Rozemuller AJ, Hulsman M, van Swieten JC, van Duijn CM, Barkhof F, Koene T, Scheltens P, Van der Flier WM, Holstege H.

J Alzheimers Dis. 2017;56(1):63-74. doi: 10.3233/JAD-160091.

13.

Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology.

Wiersma VI, van Hecke W, Scheper W, van Osch MA, Hermsen WJ, Rozemuller AJ, Hoozemans JJ.

Acta Neuropathol Commun. 2016 Oct 28;4(1):113.

14.

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy.

van Veluw SJ, Kuijf HJ, Charidimou A, Viswanathan A, Biessels GJ, Rozemuller AJ, Frosch MP, Greenberg SM.

Acta Neuropathol. 2017 Mar;133(3):409-415. doi: 10.1007/s00401-016-1635-0. Epub 2016 Oct 22.

15.

Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.

de Wit NM, Snkhchyan H, den Hoedt S, Wattimena D, de Vos R, Mulder MT, Walter J, Martinez-Martinez P, Hoozemans JJ, Rozemuller AJ, de Vries HE.

J Alzheimers Dis. 2017;60(3):795-807. doi: 10.3233/JAD-160551.

PMID:
27662305
16.

Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.

Hepp DH, Vergoossen DL, Huisman E, Lemstra AW; Netherlands Brain Bank, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD.

J Neuropathol Exp Neurol. 2016 Oct;75(10):936-945. Epub 2016 Aug 11.

PMID:
27516115
17.

Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy.

van Veluw SJ, Biessels GJ, Klijn CJ, Rozemuller AJ.

Neurology. 2016 Mar 1;86(9):867-71. doi: 10.1212/WNL.0000000000002419. Epub 2016 Feb 3.

PMID:
26843561
18.

Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease.

Hondius DC, van Nierop P, Li KW, Hoozemans JJ, van der Schors RC, van Haastert ES, van der Vies SM, Rozemuller AJ, Smit AB.

Alzheimers Dement. 2016 Jun;12(6):654-68. doi: 10.1016/j.jalz.2015.11.002. Epub 2016 Jan 6.

PMID:
26772638
19.

Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology.

Rosenberger AF, Morrema TH, Gerritsen WH, van Haastert ES, Snkhchyan H, Hilhorst R, Rozemuller AJ, Scheltens P, van der Vies SM, Hoozemans JJ.

J Neuroinflammation. 2016 Jan 6;13:4. doi: 10.1186/s12974-015-0470-x.

20.

Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces.

van Veluw SJ, Biessels GJ, Bouvy WH, Spliet WG, Zwanenburg JJ, Luijten PR, Macklin EA, Rozemuller AJ, Gurol ME, Greenberg SM, Viswanathan A, Martinez-Ramirez S.

J Cereb Blood Flow Metab. 2016 Mar;36(3):576-80. doi: 10.1177/0271678X15620434. Epub 2015 Dec 7.

21.

Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease.

Maat P, de Beukelaar JW, Jansen C, Schuur M, van Duijn CM, van Coevorden MH, de Graaff E, Titulaer M, Rozemuller AJ, Sillevis Smitt P.

Neurol Neuroimmunol Neuroinflamm. 2015 Nov 12;2(6):e178. doi: 10.1212/NXI.0000000000000178. eCollection 2015 Dec.

22.

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.

Rosenberger AF, Hilhorst R, Coart E, García Barrado L, Naji F, Rozemuller AJ, van der Flier WM, Scheltens P, Hoozemans JJ, van der Vies SM.

J Alzheimers Dis. 2016;49(4):927-43. doi: 10.3233/JAD-150429.

23.

The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, La Joie R, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, Miller BL, Barkhof F, Jagust WJ, Scheltens P, Seeley WW, Rabinovici GD.

Brain. 2015 Sep;138(Pt 9):2732-49. doi: 10.1093/brain/awv191. Epub 2015 Jul 2.

24.

Dickkopf-related protein 3 is a potential Aβ-associated protein in Alzheimer's Disease.

Bruggink KA, Kuiperij HB, Gloerich J, Otte-Höller I, Rozemuller AJ, Claassen JA, Küsters B, Verbeek MM.

J Neurochem. 2015 Sep;134(6):1152-62. doi: 10.1111/jnc.13216. Epub 2015 Jul 16.

25.

Clinico-Pathological Correlations of the Frontal Lobe Syndrome: Results of a Large Brain Bank Study.

Krudop WA, Bosman S, Geurts JJ, Sikkes SA, Verwey NA, Stek ML, Scheltens P, Rozemuller AJ, Pijnenburg YA.

Dement Geriatr Cogn Disord. 2015;40(3-4):121-9. doi: 10.1159/000430460. Epub 2015 Jun 12.

PMID:
26088035
26.

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.

Dijkstra AA, Ingrassia A, de Menezes RX, van Kesteren RE, Rozemuller AJ, Heutink P, van de Berg WD.

PLoS One. 2015 Jun 18;10(6):e0128651. doi: 10.1371/journal.pone.0128651. eCollection 2015.

27.

The spectrum of MR detectable cortical microinfarcts: a classification study with 7-tesla postmortem MRI and histopathology.

van Veluw SJ, Zwanenburg JJ, Rozemuller AJ, Luijten PR, Spliet WG, Biessels GJ.

J Cereb Blood Flow Metab. 2015 Mar 31;35(4):676-83. doi: 10.1038/jcbfm.2014.258.

28.

Reply: PRKAR1B mutations are a rare cause of FUS negative neuronal intermediate filament inclusion disease.

Wong TH, Verkerk AJ, Rozemuller AJ, Willemsen R, Neumann M, Bonifati V, van Swieten J.

Brain. 2015 Jun;138(Pt 6):e358. doi: 10.1093/brain/awu333. Epub 2014 Nov 19. No abstract available.

29.

Huntington's disease is a four-repeat tauopathy with tau nuclear rods.

Fernández-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJ, Ferrer I, Rozemuller AJ, Hernández F, Avila J, Lucas JJ.

Nat Med. 2014 Aug;20(8):881-5. doi: 10.1038/nm.3617. Epub 2014 Jul 20.

PMID:
25038828
30.

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer's disease correlates with pathology.

Rosenberger AF, Rozemuller AJ, van der Flier WM, Scheltens P, van der Vies SM, Hoozemans JJ.

Acta Neuropathol Commun. 2014 Jul 16;2:79. doi: 10.1186/s40478-014-0079-9.

31.

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.

Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ; Netherlands Brain Bank, Rozemuller AJ, van de Berg WD.

Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952. Epub 2014 Jul 3.

PMID:
24996051
32.

PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.

Wong TH, Chiu WZ, Breedveld GJ, Li KW, Verkerk AJ, Hondius D, Hukema RK, Seelaar H, Frick P, Severijnen LA, Lammers GJ, Lebbink JH, van Duinen SG, Kamphorst W, Rozemuller AJ; Netherlands Brain Bank, Bakker EB; International Parkinsonism Genetics Network, Neumann M, Willemsen R, Bonifati V, Smit AB, van Swieten J.

Brain. 2014 May;137(Pt 5):1361-73. doi: 10.1093/brain/awu067. Epub 2014 Apr 9. Erratum in: Brain. 2015 Feb;138(Pt 2):e331.

PMID:
24722252
33.

BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease.

Del Campo M, Hoozemans JJ, Dekkers LL, Rozemuller AJ, Korth C, Müller-Schiffmann A, Scheltens P, Blankenstein MA, Jimenez CR, Veerhuis R, Teunissen CE.

Neurobiol Aging. 2014 Jul;35(7):1596-604. doi: 10.1016/j.neurobiolaging.2014.01.007. Epub 2014 Jan 13.

PMID:
24524963
34.

NG2 cells, a new trail for Alzheimer's disease mechanisms?

Nielsen HM, Ek D, Avdic U, Orbjörn C, Hansson O; Netherlands Brain Bank, Veerhuis R, Rozemuller AJ, Brun A, Minthon L, Wennström M.

Acta Neuropathol Commun. 2013 May 9;1:7. doi: 10.1186/2051-5960-1-7.

35.

Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.

Hepp DH, Ruiter AM, Galis Y, Voorn P, Rozemuller AJ, Berendse HW, Foncke EM, van de Berg WD.

J Neuropathol Exp Neurol. 2013 Dec;72(12):1162-70. doi: 10.1097/NEN.0000000000000014.

PMID:
24226265
36.

Chronic lymphocytic inflammation with Pontine perivascular enhancement responsive to steroids and fatal B-cell lymphoma--reply.

De Graaff HJ, Wattjes MP, Rozemuller AJ, Petzold A, Killestein J.

JAMA Neurol. 2013 Nov;70(11):1459-60. doi: 10.1001/jamaneurol.2013.4757. No abstract available.

PMID:
24217455
37.

Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.

Doorn KJ, Goudriaan A, Blits-Huizinga C, Bol JG, Rozemuller AJ, Hoogland PV, Lucassen PJ, Drukarch B, van de Berg WD, van Dam AM.

Brain Pathol. 2014 Mar;24(2):152-65. doi: 10.1111/bpa.12088. Epub 2013 Oct 28.

PMID:
24033473
38.

Should CLIPPERS be considered a Prelymphoma state or a new Inflammatory disease.

De Graaff HJ, Wattjes MP, Rozemuller AJ, Petzold A, Killestein J.

JAMA Neurol. 2013 Sep 1;70(9):1201. doi: 10.1001/jamaneurol.2013.3855. No abstract available.

PMID:
24030209
39.

Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide.

Verwey NA, Hoozemans JJ, Korth C, van Royen MR, Prikulis I, Wouters D, Twaalfhoven HA, van Haastert ES, Schenk D, Scheltens P, Rozemuller AJ, Blankenstein MA, Veerhuis R.

Amyloid. 2013 Sep;20(3):179-87. doi: 10.3109/13506129.2013.797389. Epub 2013 Jul 5.

PMID:
23829200
40.

Defining the conformational features of anchorless, poorly neuroinvasive prions.

Bett C, Kurt TD, Lucero M, Trejo M, Rozemuller AJ, Kong Q, Nilsson KP, Masliah E, Oldstone MB, Sigurdson CJ.

PLoS Pathog. 2013;9(4):e1003280. doi: 10.1371/journal.ppat.1003280. Epub 2013 Apr 18.

41.

MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid.

Nabuurs RJ, Natté R, de Ronde FM, Hegeman-Kleinn I, Dijkstra J, van Duinen SG, Webb AG, Rozemuller AJ, van Buchem MA, van der Weerd L.

J Alzheimers Dis. 2013;34(4):1037-49. doi: 10.3233/JAD-122215.

PMID:
23340037
42.

Neuropsychiatric symptoms in Alzheimer's disease and vascular dementia.

Echávarri C, Burgmans S, Uylings H, Cuesta MJ, Peralta V, Kamphorst W, Rozemuller AJ, Verhey FR.

J Alzheimers Dis. 2013;33(3):715-21. doi: 10.3233/JAD-2012-121003.

PMID:
23001706
43.

Association between the PRNP 1368 polymorphism and the occurrence of sporadic Creutzfeldt-Jakob disease.

Bratosiewicz-Wąsik J, Smoleń-Dzirba J, Rozemuller AJ, Jansen C, Spliet W, Jansen GH, Wąsik TJ, Liberski PP.

Prion. 2012 Sep-Oct;6(4):413-6. doi: 10.4161/pri.21773. Epub 2012 Aug 16.

44.

Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease.

Eikelenboom P, Hoozemans JJ, Veerhuis R, van Exel E, Rozemuller AJ, van Gool WA.

Alzheimers Res Ther. 2012 Jun 4;4(3):15. doi: 10.1186/alzrt118.

45.

Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects.

Jansen C, Parchi P, Capellari S, Ibrahim-Verbaas CA, Schuur M, Strammiello R, Corrado P, Bishop MT, van Gool WA, Verbeek MM, Baas F, van Saane W, Spliet WG, Jansen GH, van Duijn CM, Rozemuller AJ.

PLoS One. 2012;7(4):e36333. doi: 10.1371/journal.pone.0036333. Epub 2012 Apr 30.

46.

Association of the PRNP regulatory region polymorphisms with the occurrence of sporadic Creutzfeldt-Jakob disease.

Bratosiewicz-Wąsik J, Smoleń-Dzirba J, Watała C, Rozemuller AJ, Jansen C, Spliet W, Jansen GH, Wąsik TJ, Liberski PP.

Folia Neuropathol. 2012;50(1):68-73. Review.

47.

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bódi I, King A, Hortobágyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H.

Neuropathol Appl Neurobiol. 2013 Feb;39(2):166-78. doi: 10.1111/j.1365-2990.2012.01272.x.

PMID:
22471883
48.

Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.

Rozemuller AJ, Jansen C, Carrano A, van Haastert ES, Hondius D, van der Vies SM, Hoozemans JJ.

Neurodegener Dis. 2012;10(1-4):301-4. doi: 10.1159/000335380. Epub 2012 Mar 2.

PMID:
22398730
49.

Protein kinase activity profiling of postmortem human brain tissue.

Hoozemans JJ, Hilhorst R, Ruijtenbeek R, Rozemuller AJ, van der Vies SM.

Neurodegener Dis. 2012;10(1-4):46-8. doi: 10.1159/000335914. Epub 2012 Feb 16.

PMID:
22343098
50.

Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease.

Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W.

Neurodegener Dis. 2012;10(1-4):212-5. doi: 10.1159/000334536. Epub 2012 Feb 1. Review.

PMID:
22302012

Supplemental Content

Loading ...
Support Center